Nasdaq: BBIO
BridgeBio Pharma insiders
The officers, directors and 10% owners of BridgeBio Pharma, Inc. who hold the most stock, valued at the live BBIO price.
$78.18
BBIO today +$170K (+0.22%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 11
- Their BBIO stock
- $641M
- Market value
- $15.20B
- Held by ranked insiders
- 4.22%
Insiders by value of BBIO holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Neil Kumar | Chief Executive Officer | 5,598,126 | $438M | 2.88% | 525th |
| 2 | Charles J. Homcy | Director | 919,876 | $71.9M | 0.47% | 1924th |
| 3 | Frank McCormick | Director | 767,244 | $60.0M | 0.39% | 2240th |
| 4 | Thomas Trimarchi | President and CFO | 313,748 | $24.5M | 0.16% | 4438th |
| 5 | Ali J. Satvat | Director | 169,983 | $13.3M | <0.1% | 7082nd |
| 6 | Maricel Apuli | Chief Accounting Officer | 115,973 | $9.1M | <0.1% | 9440th |
| 7 | Brian C. Stephenson | CFO and Treasurer | 102,464 | $8.0M | <0.1% | 9997th |
| 8 | James C. Momtazee | Director | 99,070 | $7.7M | <0.1% | 7605th |
| 9 | Andrew Lo | Director | 68,662 | $5.4M | <0.1% | 10957th |
| 10 | Fred Hassan | Director | 29,879 | $2.3M | <0.1% | 9292nd |
| 11 | Brent L. Saunders | Director | 17,600 | $1.4M | <0.1% | 3423rd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for BridgeBio Pharma; see each profile for the filing.